The Evolution of Patient Centricity in Pharma (Pre-2020 to 2025): From Aspiration to Embedded Reality
Patient centricity: A defining imperative in healthcare As patient expectations evolve and regulatory bodies demand greater transparency, the pharmaceutical industry is undergoing a profound transformation in terms of patient centricity. Our latest white paper, “The Evolution of Patient Centricity in Pharma (Pre-2020 to 2025): From Aspiration to Embedded Reality,” explores how patient centricity has shifted from…...
Read MoreTop Stories
What’s Next for Global Capability Centers )?
The theme for this year’s NASSCOM GCC Summit, “The Next GCC...
MAPS 2025 Decoded: The Medical Affairs Playbook
At the MAPS Americas 2025 conference in New Orleans, one of...
Medical Affairs 2.0: GenAI as the Catalyst for
Digital and AI were hot topics underpinning many of the...
Filter
Amplifying the Patient Voice: Reflections from MAPS EMEA 2025
At this year’s MAPS EMEA 2025 Annual Meeting in London, the message was clear: the...
MAPS 2025 Decoded: The Medical Affairs Playbook for Successful Drug Launches
At the MAPS Americas 2025 conference in New Orleans, one of the pivotal discussions centered...
Medical Affairs 2.0: GenAI as the Catalyst for Change in Writing, MedComms, and Field Strategy
Digital and AI were hot topics underpinning many of the conversations at the DIA’s Medical...
Using Digital Enhancements to Maximize Engagement: How Are Pharma and Publishers Embracing Digital?
Best practices to implement digital enhancements and measure effectiveness...
17th Virtual Annual Meeting of ISMPP: A Summarized Report
Session summaries from the latest ISMPP conference on trust and equity in science, digital transformation...
Digital Therapeutics and Medical Communications: Are We Ready?
Digital Therapeutics are very new and complex, and their use will involve changing standard therapeutic...